Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.

Abstract

AIMS To test the efficacy of an accelerated fractionation schedule (concomitant boost) against standard conventional fractionation in squamous cell carcinomas of the head and neck region in our patient population. MATERIALS AND METHODS Patients were randomised to receive either conventional radiotherapy with 2 Gy/fraction/day, to a dose of 66 Gy in 33… (More)
DOI: 10.1016/j.clon.2008.01.011

Topics

Cite this paper

@article{Ghoshal2008ConcomitantBR, title={Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.}, author={Sushmita Ghoshal and Jayant Sastri Goda and Indranil Mallick and Than S. Kehwar and Suresh Chander Sharma}, journal={Clinical oncology (Royal College of Radiologists (Great Britain))}, year={2008}, volume={20 3}, pages={212-20} }